Study reveals that people exhibit in-group favoritism by cooperating with members of their group, but also show increased competition against them in resource-conflict scenarios.
Risk Adjusted Net Present Value: What is the current valuation of CRISPR Therapeutics’s CTX-112
The revenue for CTX-112 is expected to reach an annual total of $65 mn by 2038 in the US based off GlobalData’s Expiry Model. The